20/20 Onsite

20/20 Onsite 20/20 Onsite delivers comprehensive eye exams to businesses via a state-of-art mobile vision center.

20/20 Onsite (also known as 2020 Onsite) is the only provider solely dedicated to point-of-need eye assessments for clinical trials, proven to meet screening timelines, improve retention rates, and fast-track trials. This is a great way for companies to offer a unique, low-cost benefit to employees.

When your margin of error is measured in microns, there's no room for imaging failures.🚨 Silent macular changes → Missed...
10/23/2025

When your margin of error is measured in microns, there's no room for imaging failures.

🚨 Silent macular changes → Missed endpoints → Study failure
🚨 Protocol deviations → FDA delays → Budget overruns
🚨 Data variability → Audit risk → Regulatory nightmare

Point-of-need imaging strategy stops these cascades before they start.

👉 https://hubs.ly/Q03L27Zb0

Stop the cycle. The Site Playbook's 4-step framework prevents these disasters before they start.🚨 Deviations piling up →...
10/21/2025

Stop the cycle. The Site Playbook's 4-step framework prevents these disasters before they start.

🚨 Deviations piling up → Sponsor frustration
🚨 Dropout cascading → Enrollment crisis
🚨 Burnout → Staff turnover

Seamless integration. Budget guidance. Measurable results. Zero surprises.

👉 https://hubs.ly/Q03Pvf520

We’re at the International Conference on Neurology & Brain Disorders (INBC) in Orlando today! If ophthalmic safety is pa...
10/20/2025

We’re at the International Conference on Neurology & Brain Disorders (INBC) in Orlando today! If ophthalmic safety is part of your neurology program, let’s connect on practical ways to keep timelines intact without overloading sites.

What we’ll bring to the conversation:
- Point-of-need ophthalmic teams (clinic, site, or mobile) with validated equipment and proven QC workflows
- Playbooks for GLP-1 and other neuro studies that require consistent ocular monitoring across sites and timepoints
-A track record across 40+ trials and 85,000+ eye assessments supporting faster screenings and reliable data capture

DM us to meet with Katie Sigg, Account Executive, Life Sciences, on-site to pressure-test your protocol or current study operations.

GLP-1 and neurology trials demand precision measured in microns. Imaging missteps could lead to endpoint failure.Silent ...
10/17/2025

GLP-1 and neurology trials demand precision measured in microns. Imaging missteps could lead to endpoint failure.

Silent macular changes. Optic nerve degeneration. Protocol deviations. These aren't just risks; they're trial killers.

The Critical Imaging Risks eBook reveals the point-of-need strategy that prevents costly delays and ensures regulatory compliance.

✓ Strategic assessment frameworks
✓ Ex*****on excellence protocols
✓ FDA-ready data delivery

👉 https://hubs.ly/Q03MhjJq0

Here's a few pictures from last week’s OD Happy Hour!Our 20/20 Onsite Life Science ODs gathered from across the country ...
10/16/2025

Here's a few pictures from last week’s OD Happy Hour!

Our 20/20 Onsite Life Science ODs gathered from across the country to celebrate the work we’re doing in clinical trials. We are grateful for this group and the impact they make every day.

Grateful to have attended and sponsored VisionWalk alongside our friends at Beacon and Neurotech. This event is more tha...
10/14/2025

Grateful to have attended and sponsored VisionWalk alongside our friends at Beacon and Neurotech. This event is more than a fundraiser, it’s a powerful symbol of hope and the collective strength of a community determined to beat vision loss.

Every walker, volunteer, and donor moves vision science forward. Your steps fuel research, expand access, and bring real momentum to millions living with vision loss. Thank you for showing up, giving generously, and proving—together—we can make a difference.

Katie Sigg, Account Executive, Life Sciences, will be at the American Academy of Ophthalmology Annual Meeting in Orlando...
10/14/2025

Katie Sigg, Account Executive, Life Sciences, will be at the American Academy of Ophthalmology Annual Meeting in Orlando, Oct 18–20!

If you’re wrestling with ophthalmic assessments in GLP-1, neurology, retina, or IRD studies, let’s talk shop. At 20/20 Onsite, we protect ocular endpoints at the point of need with certified teams, validated equipment, and flexible delivery (Mobile Vision Clinics, Pods, and Clinic Suites). That combination helps sponsors and CROs reduce site burden, improve retention, and keep timelines intact—backed by 85,000+ patient assessments, 95+ patient NPS, and 100% screening timelines met.

Book 15 minutes with Katie during AAO: https://hubs.ly/Q03NsrCm0

We’re at OCT New England this week in Boston. If you’re working on trials with ocular endpoints (or need ophthalmic safe...
10/13/2025

We’re at OCT New England this week in Boston. If you’re working on trials with ocular endpoints (or need ophthalmic safety monitoring), let’s connect.

Chris Benevides, Director of Account Management, will be there to discuss how we bring certified, point-of-need ophthalmic assessments to sites and patients—reducing travel burden and protecting endpoints.

Grab 15 minutes with Chris: https://hubs.ly/Q03MW-pH0 or DM us.

Two out of every three people in low-income countries that need eyeglasses are unable to get them. Eye health is foundat...
10/09/2025

Two out of every three people in low-income countries that need eyeglasses are unable to get them. Eye health is foundational to learning, safety, and work. On , we’re reaffirming our mission: bring high-quality vision care closer to the people who need it, so access never determines outcomes.

Let’s make eye care accessible, available, and affordable for everyone, everywhere.

Meet Dr. Essence Johnson, OD, FAAO — a community, correctional health, and now clinical trial optometrist who has built ...
10/08/2025

Meet Dr. Essence Johnson, OD, FAAO — a community, correctional health, and now clinical trial optometrist who has built a niche practice she loves.

Her introduction to 20/20 Onsite began with one referral, “I was introduced to 20/20 Onsite by Dr. Darryl Glover, who connected me with Dr. Alina Reznic... One assignment turned into another, and now I consistently work on trials every month in the states where I’m licensed to practice.”

What keeps her coming back? The diversity of the work and the impact it makes.

“I love the type and diversity of the work we do, and how we make optometry more accessible—especially through our role in clinical trials. I’ve traveled to remote areas of Texas and to cities just outside major metroplexes to bring care directly to patients, often right outside their homes. It’s meaningful, impactful work.”

For Dr. Johnson, 20/20 Onsite offers more than just variety. It provides balance. “Working with 20/20 Onsite offers the flexibility and variety that allow me to stay connected to clinical care while also working in education and academia. It supports the niche practice I’ve grown to love.”

When asked what mindset is needed for this work, she emphasizes: “Patience and compassion are key. We’re not providing routine care, and every clinical trial has its own nuances. Attention to detail and the ability to adapt to the unique demands of each study are essential to ensuring quality care and data integrity.”

Dr. Johnson reminds us that being part of 20/20 Onsite’s OD Network means more than just clinical work—it’s about meaningful relationships, flexible practice, and making a real difference in patients’ lives.

Are you an OD looking for:
• Variety and flexibility in your schedule
• Opportunities to contribute to advancing medicine
• A chance to bring care directly to patients where they need it most
• A network of peers redefining what optometry can be

Join our OD Network.
📩 Interested in learning more? Set up a quick chat with Dr. Katherine Harkins, Director of Optometry, at kharkins@2020onsite.com

Still scrambling to integrate ophthalmic endpoints after protocol approval? That reactive approach costs time, budget, a...
10/06/2025

Still scrambling to integrate ophthalmic endpoints after protocol approval? That reactive approach costs time, budget, and participant retention. They also cause:

📋 Delayed startups
📋 Budget rework
📋 Protocol deviations
📋 Coordinator burnout

The Site Playbook reveals the 4-step framework that turns eye assessment challenges into competitive advantages, before delays hit your timeline.

Download your copy and discover when to engage, how to budget, what to expect, and why it works.
👉 https://hubs.ly/Q03L7W8d0

On Monday, our Boston clinical team came together for schools training as we gear up to kick off the back-to-school seas...
10/03/2025

On Monday, our Boston clinical team came together for schools training as we gear up to kick off the back-to-school season with visits across Boston Public Schools.

We’re grateful for every opportunity to support access to vision care in our community, and even more grateful when we get to do it together as a team. Nothing like a little mini-golf to keep the spirit high while preparing to make an impact!

A special shout out to Dr. Moy, Dr. Marhefka, and Dr. Priestly in supporting us with creating our training material and presenting it to our team!

Here’s to another school year of helping students see and succeed!

Address

Boston, MA
02110

Website

Alerts

Be the first to know and let us send you an email when 20/20 Onsite posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to 20/20 Onsite:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category